Haptoglobin binds the antiatherogenic protein apolipoprotein e - Impairment of apolipoprotein e stimulation of both lecithin: Cholesterol acyltransferase activity and cholesterol uptake by hepatocytes

FEBS Journal

Volumn 276, Issue 21, 2009, Pages 6158-6171

  Cigliano, Luisa ^a   Pugliese, Carmela R ^a   Spagnuolo, Maria S ^b   Palumbo, Rosanna ^c   Abrescia, Paolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CNR   (Italy)

^c CNR   (Italy)

Author keywords

Apolipoprotein A I; Apolipoprotein E; Haptoglobin; High density lipoprotein (HDL); Lecithin:cholesterol acyltransferase (LCAT)

Indexed keywords

APOLIPOPROTEIN E; HAPTOGLOBIN; LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN SUBUNIT; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ATHEROSCLEROSIS; BINDING AFFINITY; CHOLESTEROL ESTERIFICATION; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; ELECTROPHORESIS; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INFLAMMATION; LIVER CELL; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BINDING, COMPETITIVE; CELL LINE, TUMOR; CHOLESTEROL; HAPTOGLOBINS; HEMOGLOBINS; HEPATOCYTES; HUMANS; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL; PHOSPHATIDYLCHOLINE-STEROL O-ACYLTRANSFERASE;

EID: 70349948952     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2009.07319.x     Document Type: Article

References (44)

1. Libby P, Ridker PM Maseri A (2002) Inflammation and atherosclerosis. Circulation 105, 1135 1143.
2. Libby P (2007) Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev 65, 140 146.
3. Kontush A Chapman MJ (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol Rev 58, 342 374.
4. Rader DJ (2006) Molecular regulation of HDL metabolism and function: implications for novel therapies. J Clin Invest 116, 3090 3100.
5. Rader DJ, Alexander ET, Weibel GL, Billheimer J Rothblat GH (2009) Role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J Lipid Res 50, S189 194.
6. Spagnuolo MS, Cigliano L, D'Andrea LD, Pedone C Abrescia P (2005) Assignment of the binding site for haptoglobin on apolipoprotein A-I. J Biol Chem 280, 1193 1198.
7. Porta A, Cassano E, Balestrieri M, Bianco M, Picone R, De Stefano C Abrescia P (1999) Haptoglobin transport into human ovarian follicles and its binding to apolipoprotein A-I. Zygote 7, 67 77.
8. Kunitake ST, Carilli CT, Lau K, Protter AA, Naya-Vigne J Kane JP (1994) Identification of proteins associated with apolipoprotein A-I-containing lipoproteins purified by selected-affinity immunosorption. Biochemistry 33, 1988 1993.
9. Chapelle JP, Albert A, Smeets JP, Heusghem C Kulbertus HE (1982) Effect of the haptoglobin phenotype on the size of a myocardial infarct. N Engl J Med 307, 457 463.
10. Delanghe J, Cambier B, Langlois M, De Buyzere M, Neels H, De Bacquer D Van Cauwelaert P (1997) Haptoglobin polymorphism, a genetic risk factor in coronary artery bypass surgery. Atherosclerosis 132, 215 219.
11. Giblett E (1974) Haptoglobin. In Structure and Function of Plasma Proteins (Allison AC, ed pp. 55 72. Plenum Press, New York.
12. Langlois MR Delanghe JR (1996) Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42, 1589 1600.
13. Balestrieri M, Cigliano L, De Simone ML, Dale B Abrescia P (2001) Haptoglobin inhibits lecithin-cholesterol acyltransferase in human ovarian follicular fluid. Mol Reprod Dev 59, 186 191.
14. Cigliano L, Spagnuolo MS, Dale B, Balestrieri M Abrescia P (2001) Estradiol esterification in the human preovulatory follicle. Steroids 66, 889 896.
15. Salvatore A, Cigliano L, Bucci EM, Corpillo D, Velasco S, Carlucci A, Pedone C Abrescia P (2007) Haptoglobin binding to apolipoprotein A-I prevents damage from hydroxyl radicals on its stimulatory activity of the enzyme lecithin-cholesterol acyl-transferase. Biochemistry 46, 11158 11168.
16. Braeckman L, De Bacquer D, Delanghe J, Claeys L De Backer G (1999) Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables. Atherosclerosis 143, 383 388.
17. De Bacquer D, De Backer G, Langlois M, Delanghe J, Kesteloot H Kornitzer M (2001) Haptoglobin polymorphism as a risk factor for coronary heart disease mortality. Atherosclerosis 157, 161 166.
18. Matuszek MA, Aristoteli LP, Bannon PG, Hendel PN, Hughes CF, Jessup W, Dean RT Kritharides L (2003) Haptoglobin elutes from human atherosclerotic coronary arteries - a potential marker of arterial pathology. Atherosclerosis 168, 389 396.
19. Greenow K, Pearce NJ Ramji DP (2005) The key role of apolipoprotein E in atherosclerosis. J Mol Med 83, 329 342.
20. Curtiss LK Boisvert WA (2000) Apolipoprotein E and atherosclerosis. Curr Opin Lipidol 11, 243 251.
21. Curtiss LK, Valenta DT, Hime NJ Rye KA (2006) What is so special about apolipoprotein AI in reverse cholesterol transport? Arterioscler Thromb Vasc Biol 26, 12 19.
22. Zhao Y, Thorngate FE, Weisgraber KH, Williams DL Parks JS (2005) Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins. Biochemistry 44, 1013 1025.
23. Mahley RW Rall SC (2000) Apolipoprotein E: far more than a lipid transport protein. Annu Rev Genomics Hum Genet 1, 507 537.
24. Rademacher BE Steele WJ (1987) A general method for the isolation of haptoglobin 1-1, 1-2 and 2-2 from human plasma. Anal Biochem 160, 119 126.
25. Spagnuolo MS, Cigliano L Abrescia P (2003) The binding of haptoglobin to apolipoprotein A-I: influence of hemoglobin and cancanavalin A. Biol Chem 384, 1593 1596.
26. Schumaker VN Puppione DL (1986) Sequential flotation ultracentrifugation. In Methods in Enzymology (Segrest JP Albers JJ, eds pp 155 170. Academic Press, Orlando, Florida.
27. Shiflett AM, Bishop JR, Pahwa A Hajduk SL (2005) Human high density lipoproteins are platforms for assembly of multi-component innate immune complexes. J Biol Chem 280, 32578 32585.
28. Karlsson H, Leanderson P, Tagesson C Lindahl M (2005) Lipoproteomics I: mapping of proteins in low-density lipoprotein using two-dimensional gel electrophoresis and mass spectrometry. Proteomics 5, 551 565. (Pubitemid 40262072)
29. Xu S, Laccotripe M, Huang X, Rigotti A, Zannis VI Krieger M (1997) Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake. J Lipid Res 38, 1289 1298.
30. Scanu AM Edelstein C (2008) HDL: bridging past and present with a look at the future. FASEB J 22, 4044 4054.
31. Salvatore A, Cigliano L, Carlucci A, Bucci EM Abrescia P (2009) Haptoglobin binds apolipoprotein E and influences cholesterol esterification in the cerebrospinal fluid. J Neurochem 110, 255 263.
32. Kim WS, Rahmanto AS, Kamili A, Rye K-A, Guillemin GJ, Gelissen IC, Jessup W, Hill AF Garner B (2007) Role of ABCG1 and ABCA1 in regulation of neuronal cholesterol efflux to apolipoprotein E discs and suppression of amyloid-β peptide generation. J Biol Chem 282, 2851 2861.
33. Hirsch-Reinshagen V Wellington CL (2007) Cholesterol metabolism, apolipoprotein E, adenosine triphosphate-binding cassette transporters, and Alzheimer's disease. Curr Opin Lipidol 18, 325 332.
34. Yang DS, Small DH, Seydel U, Smith JD, Hallmayer J, Gandy SE Martins RN (1999) Apolipoprotein E promotes the binding and uptake of beta-amyloid into Chinese hamster ovary cells in an isoform-specific manner. Neuroscience 90, 1217 1226.
35. Koistinaho M, Lin S, Wu X, Esterman M, Koger D, Hanson J, Higgs R, Liu F, Malkani S, Bales KR et al. (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 10, 719 726.
36. Sadowski M, Pankiewicz J, Scholtzova H, Ripellino JA, Li Y, Schmidt SD, Mathews PM, Fryer JD, Holtzman DM, Sigurdsson EM et al. (2004) A synthetic peptide blocking the apolipoprotein E/beta-amyloid binding mitigates beta-amyloid toxicity and fibril formation in vitro and reduces beta-amyloid plaques in transgenic mice. Am J Pathol 165, 937 948.
37. Sanchez DJ, Armstrong L, Aguilar R, Adrian GS, Haro L Martinez AO (2001) Haptoglobin gene expression in human glioblastoma cell lines. Neurosci Lett 303, 181 184.
38. Lee MY, Kim SY, Choi JS, Lee IH, Choi YS, Jin JY, Park SJ, Sung KW, Chun MH Kim IS (2002) Upregulation of haptoglobin in reactive astrocytes after transient forebrain ischemia in rats. J Cereb Blood Flow Metab 22, 1176 1180.
39. Cigliano L, Spagnuolo MS Abrescia P (2003) Quantitative variations of the isoforms in haptoglobin 1-2 and 2-2 individual phenotypes. Arch Biochem Biophys 416, 227 237.
40. Chen C-H Albers JJ (1982) Characterization of proteoliposomes containing apoprotein A-I: a new substrate for the measurement of lecithin:cholesterol acyltransferase activity. J Lipid Res 23, 680 691.
41. Sparks DL, Phillips MC Lund-Katz S (1992) The conformation of apolipoprotein A-I in discoidal and spherical recombinant high density lipoprotein particles. J Biol Chem 267, 25830 25838.
42. Garcia A, Barbaras R, Collet X, Bogyo A, Chap H Perret B (1996) High-density lipoprotein 3 receptor-dependent endocytosis pathway in a human hepatoma cell line (HepG2). Biochemistry 35, 13064 13071.
43. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248 252.
44. Matz CE Jonas A (1982) Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J Biol Chem 257, 4535 4540.